EcoDrugPlus

Prostaglandin D2 Receptor 2

Ensembl ID : ENSHCOG00000014340
Gene Symbol: PTGDR2
4 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSHCOG00000002221
Gene Symbol: PTGER2
3 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSHCOG00000016955
Gene Symbol: PTGER3
1 Cross references
193 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSHCOG00000016945
Gene Symbol: PTGER3
3 Cross references
193 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSHCOG00000019818
Gene Symbol: LOC109527389
4 Cross references
167 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSHCOG00000019485
Gene Symbol: LOC109530041
3 Cross references
164 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSHCOG00000004298
Gene Symbol: LOC109526733
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSHCOG00000001714
Gene Symbol: LOC109517182
3 Cross references
201 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSHCOG00000000797
Gene Symbol: PTGFR
1 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 1-Like

Ensembl ID : ENSHCOG00000000092
Gene Symbol: LOC109520402
3 Cross references
182 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSHCOG00000007014
Gene Symbol: PTGIR
3 Cross references
187 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSHCOG00000020268
Gene Symbol: PTGS1
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).